Rounding Out National Cancer Research Month
As we round out National Cancer Research Month, we want to highlight the important work being done by FidoCure researchers in comparative oncology. At FidoCure, we’ve pioneered canine cancer research backed by real-world evidence and published our findings in 4 of the most prestigious peer-reviewed scientific journals. Many of these papers are go-to sources for […]
FidoCure Brings Precision Medicine to the Forefront of Canine Cancer
One out of four pet dogs will be diagnosed with cancer throughout their lifetime. With nearly 6 million new canine cancer diagnoses each year, there is an urgent need for advanced treatments. Fortunately, FidoCure introduces advanced options into the cancer treatment toolbox for veterinarians and dogs, offering hope for improved outcomes.
Small Molecules, Big Impact: An Interview with Dr. Cheryl London
Explore the history and impact of small molecules in this fascinating discussion. FidoCure’s Chief Medical Officer, Dr. Gerry Post interviews Dr. Cheryl London about their application in canine cancer treatment. Dr. Cheryl London is a world-renowned expert in veterinary oncology and targeted cancer therapies at Tufts University. Her pioneering work began in 2000 when she […]
Understanding Hemangiosarcoma in Dogs: Treatment Options and Prognosis
Hemangiosarcoma is an aggressive, malignant tumor derived from blood vessel cells that grows rapidly, can cause severe bleeding, and has a high metastasis rate. It most commonly affects the spleen but can also occur in the heart, skin, and liver, with certain breeds like German Shepherds, Golden Retrievers, and Labradors at higher risk. Treatment typically […]
Unlocking Precision Oncology: Insights from Top Articles & Canine Cancer Studies
Precision medicine revolutionizes cancer care by tailoring treatments to each patient’s tumor, but major roadblocks remain. These top articles dive into the key challenges holding personalized oncology back and emerging solutions companies like FidoCure are exploring. You’ll find insights on innovative clinical trial designs, cutting-edge technologies enabling more precise therapies, and even how studying cancer […]
Canine Transitional Cell Carcinoma: Treatment Options and Prognosis
Transitional cell carcinoma (TCC) is the most common tumor affecting canine urinary bladders. It is highly invasive, can obstruct urinary outflow, and has a moderate metastasis rate in areas like lymph nodes and lungs. Several factors increase TCC risk, including older flea products, lawn chemicals, obesity, being female, and certain breeds like Scottish Terriers and […]
Adenocarcinoma Pet Parent Testimonial: Sammy
At the heart of veterinary science lies a deep compassion for the well-being of our beloved animal companions. This is where FidoCure can make a profound impact on the quality of life of your pet battling cancer by offering hope with targeted therapy to thousands of dogs through genomic sequencing and AI-driven data analysis of […]
World Vet Day: Hear from Pet Parents
On World Vet Day, we wanted to express our heartfelt gratitude to all our veterinarians and vet techs who work with our dogs. In recognition, we asked FidoCure pet parents to nominate their vets and tell us why they’ve made such an immense impact on the lives of their dogs.
We’ve Reached 5000 Patients!
We are thrilled to share with you an incredible milestone in our journey to revolutionize canine cancer treatment. Thanks to your unwavering support and dedication, we have now enrolled over 5,000 dogs in the FidoCure platform! This achievement is a testament to the trust you have placed in our innovative approach and the positive impact […]
Dr. Fabian Kausche Joins FidoCure Advisory Board
Leading Animal Health Expert Dr. Fabian Kausche Joins FidoCure Advisory Board
